Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on ortho and osteobiologics market provides an
in-depth analysis of segments and sub-segments in the global as well as
regional ortho and osteobiologics market. The study also highlights the impact
of drivers, restraints, and macro indicators on the global and regional ortho
and osteobiologics market over the short term as well as long term. The report
is a comprehensive presentation of trends, forecast and dollar values of global
ortho and osteobiologics market. According to the report, the global ortho and
osteobiologics market is projected to grow at a CAGR of 6.24% over the forecast
period of 2018-2024.
Orthobiologics are naturally
present substances in the body that orthopedic surgeons use to help injuries
heal more quickly. Osteobiologics are engineered materials that have been
created as substitutes for natural substances to promote the healing of
fractures and bone defects. Ortho and osteobiologics are used to improve the
healing of broken bones and injured muscles, tendons, and ligaments. Ortho and
osteobiologics substances include bone grafts, autologous blood, platelet-rich
plasma (PRP), autologous conditioned serum and stem cells dons, and ligaments.
The list of osteobiologics is rapidly expanding as new products incorporating
osteoconductive materials are mixed with a variety of osteoinductive proteins,
demineralized bone, and preparations of osteogenic cells.
Orthobiologics is a rapidly
advancing field utilizing cell-based therapies and biomaterials to enable the
body, to repair and regenerate musculoskeletal tissues. The current metal
implants made of stainless steel or titanium that are rigid and bioinert are
not favorable for enhancing fracture healing and subsequent remodeling.
Therefore, after years of research and development, scientists have proposed an
innovative hybrid fixation system with parts composed of magnesium and titanium
or stainless steel. Hybrid fixation system is used to maximize the biological
benefits of magnesium, especially in patients with osteoporosis and other
metabolic disorders that are unfavorable conditions for fracture healing.
The rise in aging population and
growth in the number of people suffering from spinal and bone disorders such as
arthritis and fibromyalgia are driving the ortho and osteobiologics market.
Arthritis prevalence increases with age. Moreover, the use of ortho and
osteobiologic offers benefits such as the minimal impact of degenerative
disease and rapid recovery than surgery, thus promoting the growth of this
market. The growth in ortho and osteobiologics has been stimulated by the
increasing demand for allografts in all areas of orthopedics owing to the rising
number of sports injuries and road accidents. The number of donors has grown
much slower than demand leading to the development of artificial materials,
thus promoting the growth of the osteobiologics market. The osteobiologics
attempt to mimic the components of an autogenous bone graft by reproducing the
bone matrix, which is osteoconductive and osteoinductive. Furthermore, the
recent increase in the use of bone graft substitutes in the repair of fractures
is boosting the ortho and osteobiologics market. Bone grafting and various forms
of fixation account for 2.2 million procedures worldwide annually. There is a
rising demand for ortho and osteobiologic products owing to the low cost and
higher success-rate of the treatment. However, the lack of FDA approval hampers
the growth of the ortho and osteobiologics market. Moreover, the ongoing
development in the arena of ortho and osteobiologics and its growing uses in
foot and ankle surgeries are anticipated to create the opportunities for the
growth of ortho and osteobiologics market. Among the geographies, North America
dominated the ortho and osteobiologics market in the year 2017. The increasing
use of bone grafting, high disposable income and the benefits offered by ortho
and osteobiologics drives the growth of ortho and osteobiologics market in this
region. Europe is the second largest ortho and osteobiologics market owing to
the growth of the elderly population and the rising occurrences of arthritis in
this region. Asia-Pacific is the fastest growing region in the ortho and
osteobiologics market. Rising prevalence of fractures and injuries owing to
road accidents, sports injuries facilitates the growth of the ortho and
osteobiologics market in the Asia-Pacific region.
Among the geographies, North
America dominated the ortho and osteobiologics market in the year 2017. The
increasing use of bone grafting, high disposable income and the benefits
offered by ortho and osteobiologics drives the growth of ortho and
osteobiologics market in this region. Europe is the second largest ortho and
osteobiologics market owing to the growth of the elderly population and the
rising occurrences of arthritis in this region. Asia-Pacific is the fastest
growing region in the ortho and osteobiologics market. Rising prevalence of
fractures and injuries owing to road accidents, sports injuries facilitates the
growth of the ortho and the market in the Asia-Pacific region.
The report on global ortho and
osteobiologics market covers segments such as product, application, and
end-user. On the basis of the product, the global ortho and osteobiologics market
is categorized into visco-supplementation products, demineralized bone
matrices, synthetic orthobiologics, bone morphogenic protein, allografts,
plasma-rich protein, and bone marrow aspirate concentrate. On the basis of
application, the global ortho, and osteobiologics market is categorized into
osteoarthritis and degenerative arthritis, spinal fusion, soft-tissue injuries,
fracture recovery, and maxillofacial and dental applications. On the basis of
end-user, the global ortho, and osteobiologics market is categorized into
hospitals, research & academic institutes, specialty clinics, and dental
clinics and facilities.
The report provides regional
analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section, the key trends and market size for each
geography are provided over the period of 2016-2024. The countries covered in
the North America region include the U.S., Canada, and Mexico; while the
Asia-Pacific region includes countries such as China, Japan, India, South
Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and
Rest of Europe are the major markets included in the European region. The U.S.
drives the growth in the North America region, as it is the largest market in
the region. In the Asia-Pacific region, rapid industrial growth in India and
China offers substantial potential for the growth in the ortho and
osteobiologics market. As a result, the APAC region is projected to experience growth at a CAGR of x.x% over the forecast period 2018-2024.
The report provides profiles of the companies in the global ortho and osteobiologics market such as Medtronic, DePuy Synthes, Zimmer Biomet, Stryker Corporation, Orthofix, K2M, Inc., LifeNet Health, Inc., Fuse Medical, Inc., NuVasive, Inc., and Wright Medical Group N.V.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the global ortho and osteobiologics market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of ortho and osteobiologics market. Moreover,
the study highlights current market trends and provides forecast from
2018-2024. We also have highlighted future trends in the ortho and
osteobiologics market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight into the market share of the leading players. This report will help
manufacturers, suppliers, and distributors of the ortho and osteobiologics
market to understand the present and future trends in this market and formulate
their strategies accordingly.
Please Choose One of them.